ecrin-mdr-crcClinical2015Abdominal CancerComplianceIPD Sharing (as of November 2018): NoAbdominal CancerComplianceInterventionalhttps://newmdr.ecrin.org/Study/2290304Denmark5ECRIN MDRCompletedfalseImprovement of Compliance for High Doses of EPA Amongst Patients With Colorectal CancerSeveral studies indicate beneficial effects of eicosapentanoic acid (EPA) on cancer cachexia. However, compliance is generally low. This case control study is conducted in order to investigate if compliance depends upon the physical properties of the supplement (capsules vs. drinks). In order to further investigate how compliance can be improved, a possible correlation between sideeffects and rate of increased polyunsaturated fatty acid concentration in blood is also tested2015-05-152290304NCT03751384